nodes	percent_of_prediction	percent_of_DWPC	metapath
Decamethonium—BCHE—multiple sclerosis	0.863	1	CbGaD
Decamethonium—BCHE—Triamcinolone—multiple sclerosis	0.036	1	CbGbCtD
Decamethonium—HRH3—brainstem—multiple sclerosis	0.00389	0.0881	CbGeAlD
Decamethonium—Succinylcholine—BCHE—multiple sclerosis	0.0037	0.583	CrCbGaD
Decamethonium—CHRNG—medulla oblongata—multiple sclerosis	0.00331	0.075	CbGeAlD
Decamethonium—CHRNG—midbrain—multiple sclerosis	0.00302	0.0685	CbGeAlD
Decamethonium—Sodium lauryl sulfate—ALB—multiple sclerosis	0.00265	0.417	CrCbGaD
Decamethonium—HRH3—nervous system—multiple sclerosis	0.00204	0.0461	CbGeAlD
Decamethonium—HRH3—central nervous system—multiple sclerosis	0.00196	0.0444	CbGeAlD
Decamethonium—HRH3—cerebellum—multiple sclerosis	0.00192	0.0434	CbGeAlD
Decamethonium—CHRNB1—medulla oblongata—multiple sclerosis	0.00169	0.0383	CbGeAlD
Decamethonium—HRH3—brain—multiple sclerosis	0.00156	0.0353	CbGeAlD
Decamethonium—CHRNB1—midbrain—multiple sclerosis	0.00155	0.035	CbGeAlD
Decamethonium—CHRNB1—spinal cord—multiple sclerosis	0.00151	0.0342	CbGeAlD
Decamethonium—ACHE—medulla oblongata—multiple sclerosis	0.00147	0.0332	CbGeAlD
Decamethonium—CHRNA2—nervous system—multiple sclerosis	0.00137	0.0309	CbGeAlD
Decamethonium—ACHE—midbrain—multiple sclerosis	0.00134	0.0304	CbGeAlD
Decamethonium—CHRNA2—central nervous system—multiple sclerosis	0.00131	0.0298	CbGeAlD
Decamethonium—ACHE—spinal cord—multiple sclerosis	0.00131	0.0296	CbGeAlD
Decamethonium—CHRNA2—cerebellum—multiple sclerosis	0.00128	0.0291	CbGeAlD
Decamethonium—CHRNA1—brain—multiple sclerosis	0.00126	0.0285	CbGeAlD
Decamethonium—CHRNB1—cerebellum—multiple sclerosis	0.0012	0.0271	CbGeAlD
Decamethonium—CHRNA2—brain—multiple sclerosis	0.00104	0.0237	CbGeAlD
Decamethonium—ACHE—cerebellum—multiple sclerosis	0.00104	0.0235	CbGeAlD
Decamethonium—BCHE—brainstem—multiple sclerosis	0.00103	0.0234	CbGeAlD
Decamethonium—CHRNB1—brain—multiple sclerosis	0.000971	0.022	CbGeAlD
Decamethonium—ACHE—brain—multiple sclerosis	0.000842	0.0191	CbGeAlD
Decamethonium—CHRM2—nervous system—multiple sclerosis	0.000814	0.0185	CbGeAlD
Decamethonium—CHRM2—central nervous system—multiple sclerosis	0.000784	0.0178	CbGeAlD
Decamethonium—BCHE—medulla oblongata—multiple sclerosis	0.000721	0.0163	CbGeAlD
Decamethonium—BCHE—midbrain—multiple sclerosis	0.000659	0.0149	CbGeAlD
Decamethonium—BCHE—spinal cord—multiple sclerosis	0.000643	0.0146	CbGeAlD
Decamethonium—CHRM2—brain—multiple sclerosis	0.000622	0.0141	CbGeAlD
Decamethonium—BCHE—nervous system—multiple sclerosis	0.000541	0.0123	CbGeAlD
Decamethonium—BCHE—central nervous system—multiple sclerosis	0.000521	0.0118	CbGeAlD
Decamethonium—BCHE—cerebellum—multiple sclerosis	0.000509	0.0115	CbGeAlD
Decamethonium—BCHE—brain—multiple sclerosis	0.000414	0.00938	CbGeAlD
Decamethonium—CHRNE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.00015	0.00296	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000146	0.00289	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000146	0.00289	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—LINGO1—multiple sclerosis	0.000146	0.00288	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000144	0.00285	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CCR1—multiple sclerosis	0.000144	0.00285	CbGpPWpGaD
Decamethonium—HRH3—G alpha (i) signalling events—POMC—multiple sclerosis	0.000144	0.00284	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—CXCL10—multiple sclerosis	0.000144	0.00284	CbGpPWpGaD
Decamethonium—BCHE—Peptide hormone metabolism—POMC—multiple sclerosis	0.000138	0.00274	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CCR1—multiple sclerosis	0.000138	0.00272	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CXCL13—multiple sclerosis	0.000138	0.00272	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000134	0.00266	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000134	0.00266	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000134	0.00264	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Other—CCR5—multiple sclerosis	0.000128	0.00252	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TAGAP—multiple sclerosis	0.000126	0.00249	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000125	0.00247	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—CCL5—multiple sclerosis	0.000124	0.00244	CbGpPWpGaD
Decamethonium—CHRNG—Neuronal System—MAPK1—multiple sclerosis	0.000122	0.00241	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.00012	0.00238	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—S1PR1—multiple sclerosis	0.000118	0.00234	CbGpPWpGaD
Decamethonium—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000118	0.00233	CbGpPWpGaD
Decamethonium—ACHE—ATF-2 transcription factor network—MAPK1—multiple sclerosis	0.000118	0.00232	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—BCHE—multiple sclerosis	0.000116	0.00229	CbGpPWpGaD
Decamethonium—CHRNE—Neuronal System—MAPK1—multiple sclerosis	0.000115	0.00227	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000114	0.00226	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000114	0.00226	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000114	0.00226	CbGpPWpGaD
Decamethonium—HRH3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000112	0.00221	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—CCR5—multiple sclerosis	0.000111	0.0022	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—S1PR1—multiple sclerosis	0.00011	0.00218	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GPC5—multiple sclerosis	0.000107	0.00212	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000106	0.0021	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000104	0.00205	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000103	0.00204	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.0001	0.00198	CbGpPWpGaD
Decamethonium—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.0001	0.00198	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CCL3—multiple sclerosis	9.81e-05	0.00194	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CCR2—multiple sclerosis	9.77e-05	0.00193	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	9.61e-05	0.0019	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CXCR3—multiple sclerosis	9.54e-05	0.00189	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—GPR65—multiple sclerosis	9.53e-05	0.00188	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—SRM—multiple sclerosis	9.53e-05	0.00188	CbGpPWpGaD
Decamethonium—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	9.52e-05	0.00188	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—SLC30A7—multiple sclerosis	9.47e-05	0.00187	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—PTGER4—multiple sclerosis	9.44e-05	0.00187	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—RGS1—multiple sclerosis	9.38e-05	0.00185	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CCR2—multiple sclerosis	9.28e-05	0.00183	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	9.18e-05	0.00181	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	9.17e-05	0.00181	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CXCR3—multiple sclerosis	9.12e-05	0.0018	CbGpPWpGaD
Decamethonium—ACHE—ATF-2 transcription factor network—IL6—multiple sclerosis	9.03e-05	0.00178	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CNR1—multiple sclerosis	9.01e-05	0.00178	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—GPR65—multiple sclerosis	8.89e-05	0.00176	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CCR2—multiple sclerosis	8.87e-05	0.00175	CbGpPWpGaD
Decamethonium—CHRND—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	8.86e-05	0.00175	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	8.85e-05	0.00175	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CXCL13—multiple sclerosis	8.72e-05	0.00172	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CCR1—multiple sclerosis	8.72e-05	0.00172	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—POMC—multiple sclerosis	8.7e-05	0.00172	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	8.61e-05	0.0017	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—PABPC1—multiple sclerosis	8.59e-05	0.0017	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CNR1—multiple sclerosis	8.56e-05	0.00169	CbGpPWpGaD
Decamethonium—HRH3—GPCR ligand binding—CCL2—multiple sclerosis	8.52e-05	0.00168	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—SRM—multiple sclerosis	8.5e-05	0.00168	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CNR1—multiple sclerosis	8.19e-05	0.00162	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	8.16e-05	0.00161	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CXCL13—multiple sclerosis	8.13e-05	0.00161	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCR1—multiple sclerosis	8.13e-05	0.00161	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CXCL10—multiple sclerosis	8.12e-05	0.0016	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	7.95e-05	0.00157	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	7.85e-05	0.00155	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—RPL5—multiple sclerosis	7.75e-05	0.00153	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CXCL10—multiple sclerosis	7.71e-05	0.00152	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—PABPC1—multiple sclerosis	7.66e-05	0.00151	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	7.58e-05	0.0015	CbGpPWpGaD
Decamethonium—CHRNA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.53e-05	0.00149	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	7.38e-05	0.00146	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CXCL10—multiple sclerosis	7.37e-05	0.00146	CbGpPWpGaD
Decamethonium—CHRNA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.15e-05	0.00141	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CCL5—multiple sclerosis	6.99e-05	0.00138	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—RPL5—multiple sclerosis	6.91e-05	0.00137	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	6.81e-05	0.00135	CbGpPWpGaD
Decamethonium—CHRND—Neuronal System—MAPK1—multiple sclerosis	6.79e-05	0.00134	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP27B1—multiple sclerosis	6.71e-05	0.00133	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—CYP24A1—multiple sclerosis	6.71e-05	0.00133	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—S1PR1—multiple sclerosis	6.68e-05	0.00132	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CCL5—multiple sclerosis	6.64e-05	0.00131	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.56e-05	0.0013	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CCL5—multiple sclerosis	6.34e-05	0.00125	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—CCR5—multiple sclerosis	6.29e-05	0.00124	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CCL3—multiple sclerosis	6.21e-05	0.00123	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—IL2RA—multiple sclerosis	6.2e-05	0.00123	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—GPC5—multiple sclerosis	6.14e-05	0.00121	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	6.13e-05	0.00121	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—S1PR1—multiple sclerosis	6.07e-05	0.0012	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP24A1—multiple sclerosis	5.99e-05	0.00118	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—CYP27B1—multiple sclerosis	5.99e-05	0.00118	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—PTGER4—multiple sclerosis	5.98e-05	0.00118	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—CCR5—multiple sclerosis	5.98e-05	0.00118	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCL3—multiple sclerosis	5.79e-05	0.00115	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CXCR3—multiple sclerosis	5.78e-05	0.00114	CbGpPWpGaD
Decamethonium—CHRNA1—Neuronal System—MAPK1—multiple sclerosis	5.77e-05	0.00114	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CCR5—multiple sclerosis	5.72e-05	0.00113	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—RGS1—multiple sclerosis	5.68e-05	0.00112	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—BCHE—multiple sclerosis	5.67e-05	0.00112	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—IL2RA—multiple sclerosis	5.63e-05	0.00111	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CCR2—multiple sclerosis	5.62e-05	0.00111	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PTGER4—multiple sclerosis	5.58e-05	0.0011	CbGpPWpGaD
Decamethonium—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	5.55e-05	0.0011	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—PGR—multiple sclerosis	5.49e-05	0.00109	CbGpPWpGaD
Decamethonium—CHRNA2—Neuronal System—MAPK1—multiple sclerosis	5.48e-05	0.00108	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—GPC5—multiple sclerosis	5.48e-05	0.00108	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—GPR65—multiple sclerosis	5.39e-05	0.00106	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CXCR3—multiple sclerosis	5.39e-05	0.00106	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CD28—multiple sclerosis	5.34e-05	0.00105	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	5.28e-05	0.00104	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCR2—multiple sclerosis	5.24e-05	0.00104	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CNR1—multiple sclerosis	5.18e-05	0.00102	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—RGS1—multiple sclerosis	5.16e-05	0.00102	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—RRM1—multiple sclerosis	5.09e-05	0.00101	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CCR1—multiple sclerosis	4.93e-05	0.000974	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CXCL13—multiple sclerosis	4.93e-05	0.000974	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—POMC—multiple sclerosis	4.92e-05	0.000972	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—GPR65—multiple sclerosis	4.89e-05	0.000967	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CNR1—multiple sclerosis	4.84e-05	0.000956	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.81e-05	0.000951	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	4.75e-05	0.00094	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—LINGO1—multiple sclerosis	4.73e-05	0.000935	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.69e-05	0.000928	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.68e-05	0.000925	CbGpPWpGaD
Decamethonium—CHRM2—G alpha (i) signalling events—POMC—multiple sclerosis	4.67e-05	0.000924	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CXCL10—multiple sclerosis	4.67e-05	0.000923	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.59e-05	0.000908	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—RRM1—multiple sclerosis	4.54e-05	0.000897	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CXCL13—multiple sclerosis	4.47e-05	0.000884	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CCR1—multiple sclerosis	4.47e-05	0.000884	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—POMC—multiple sclerosis	4.47e-05	0.000883	CbGpPWpGaD
Decamethonium—ACHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.43e-05	0.000875	CbGpPWpGaD
Decamethonium—ACHE—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.37e-05	0.000864	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—CCL2—multiple sclerosis	4.37e-05	0.000864	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CXCL10—multiple sclerosis	4.35e-05	0.00086	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	4.1e-05	0.000811	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	4.02e-05	0.000794	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—TYK2—multiple sclerosis	3.97e-05	0.000784	CbGpPWpGaD
Decamethonium—BCHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.95e-05	0.00078	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.95e-05	0.00078	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CD86—multiple sclerosis	3.81e-05	0.000752	CbGpPWpGaD
Decamethonium—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	3.8e-05	0.000752	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCL5—multiple sclerosis	3.75e-05	0.000741	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	3.72e-05	0.000734	CbGpPWpGaD
Decamethonium—HRH3—GPCR downstream signaling—IL2—multiple sclerosis	3.64e-05	0.000719	CbGpPWpGaD
Decamethonium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	3.64e-05	0.000718	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	3.62e-05	0.000715	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	3.58e-05	0.000709	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.52e-05	0.000696	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.49e-05	0.00069	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	3.49e-05	0.000689	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—SPP1—multiple sclerosis	3.47e-05	0.000686	CbGpPWpGaD
Decamethonium—ACHE—Neuronal System—MAPK1—multiple sclerosis	3.39e-05	0.00067	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.39e-05	0.00067	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	3.38e-05	0.000668	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCR5—multiple sclerosis	3.38e-05	0.000667	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL2RA—multiple sclerosis	3.33e-05	0.000658	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—IL2—multiple sclerosis	3.3e-05	0.000653	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	3.26e-05	0.000645	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	3.19e-05	0.00063	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	3.17e-05	0.000627	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.09e-05	0.000611	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—APOE—multiple sclerosis	3.07e-05	0.000607	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	3.07e-05	0.000606	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	3.05e-05	0.000602	CbGpPWpGaD
Decamethonium—BCHE—Neuronal System—MAPK1—multiple sclerosis	3.03e-05	0.000598	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.02e-05	0.000598	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	2.96e-05	0.000586	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	2.93e-05	0.000579	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—POMC—multiple sclerosis	2.93e-05	0.000579	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—BCHE—multiple sclerosis	2.92e-05	0.000577	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	2.89e-05	0.000571	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	2.88e-05	0.00057	CbGpPWpGaD
Decamethonium—ACHE—Metabolism of proteins—CCL2—multiple sclerosis	2.87e-05	0.000567	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	2.83e-05	0.000559	CbGpPWpGaD
Decamethonium—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.82e-05	0.000557	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CD80—multiple sclerosis	2.78e-05	0.000549	CbGpPWpGaD
Decamethonium—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	2.77e-05	0.000547	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.76e-05	0.000545	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	2.66e-05	0.000526	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	2.64e-05	0.000522	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	2.64e-05	0.000522	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—POMC—multiple sclerosis	2.64e-05	0.000522	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	2.64e-05	0.000521	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—POMC—multiple sclerosis	2.61e-05	0.000517	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—CCL2—multiple sclerosis	2.58e-05	0.00051	CbGpPWpGaD
Decamethonium—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	2.56e-05	0.000505	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—MAPK1—multiple sclerosis	2.53e-05	0.000499	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	2.4e-05	0.000473	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TYK2—multiple sclerosis	2.34e-05	0.000463	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	2.27e-05	0.000449	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	2.06e-05	0.000408	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	2.05e-05	0.000404	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.02e-05	0.000398	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL2—multiple sclerosis	1.95e-05	0.000386	CbGpPWpGaD
Decamethonium—HRH3—Signaling by GPCR—IL6—multiple sclerosis	1.94e-05	0.000384	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	1.88e-05	0.000372	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	1.86e-05	0.000367	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MMP9—multiple sclerosis	1.85e-05	0.000365	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	1.83e-05	0.000362	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	1.81e-05	0.000358	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—PGR—multiple sclerosis	1.79e-05	0.000353	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—APOE—multiple sclerosis	1.76e-05	0.000347	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	1.75e-05	0.000346	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CD28—multiple sclerosis	1.73e-05	0.000343	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	1.7e-05	0.000337	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—STAT3—multiple sclerosis	1.64e-05	0.000324	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	1.6e-05	0.000316	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	1.57e-05	0.000311	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—APOE—multiple sclerosis	1.57e-05	0.00031	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MYC—multiple sclerosis	1.53e-05	0.000301	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—TGFB1—multiple sclerosis	1.52e-05	0.000301	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—POMC—multiple sclerosis	1.51e-05	0.000298	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—MAPK1—multiple sclerosis	1.49e-05	0.000295	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	1.45e-05	0.000287	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	1.42e-05	0.000281	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	1.42e-05	0.00028	CbGpPWpGaD
Decamethonium—ACHE—Metabolism—ALB—multiple sclerosis	1.38e-05	0.000272	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—POMC—multiple sclerosis	1.35e-05	0.000266	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.29e-05	0.000255	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.24e-05	0.000245	CbGpPWpGaD
Decamethonium—BCHE—Metabolism—ALB—multiple sclerosis	1.23e-05	0.000243	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.22e-05	0.000241	CbGpPWpGaD
Decamethonium—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.18e-05	0.000234	CbGpPWpGaD
Decamethonium—HRH3—Signaling Pathways—IL6—multiple sclerosis	1.15e-05	0.000227	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.13e-05	0.000223	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.1e-05	0.000217	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.08e-05	0.000214	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.07e-05	0.000212	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—APOE—multiple sclerosis	9.98e-06	0.000197	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CD80—multiple sclerosis	9.03e-06	0.000178	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—POMC—multiple sclerosis	8.58e-06	0.00017	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	8.39e-06	0.000166	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	8.21e-06	0.000162	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	7.62e-06	0.000151	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL2—multiple sclerosis	6.34e-06	0.000125	CbGpPWpGaD
Decamethonium—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	6.31e-06	0.000125	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	6e-06	0.000119	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	5.34e-06	0.000105	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MYC—multiple sclerosis	4.96e-06	9.8e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	4.95e-06	9.78e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	4.85e-06	9.59e-05	CbGpPWpGaD
Decamethonium—CHRM2—Signaling Pathways—IL6—multiple sclerosis	3.73e-06	7.37e-05	CbGpPWpGaD
